Ultrapotent, nanoparticle COVID-19 vaccine with Univ. of Wash. roots gets $173M for human trials
An image of the nanoparticle with spike proteins used in a newly developed COVID-19 vaccine candidate. (Ian Haydon / UW Institute for Protein Design) A project to test what is known as an ultrapotent second-generation COVID-19 vaccine candidate will receive up to $ 173.4 million to conduct Phase 3 clinical trials. The vaccine was developed … Read more